Sorry, you need to enable JavaScript to visit this website.

色噜噜综合色在线视频

<object id="6k4cv"><li id="6k4cv"></li></object>
    1. <code id="6k4cv"></code>

    2. <strike id="6k4cv"></strike>

      1. <code id="6k4cv"></code>
      2. <tr id="6k4cv"></tr>
        Profile and Organization

        Names, Facts, Figures about Bayer

        Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

        bayer-cross-in-shanghai-en-300x200
        The Bayer Cross is one of the world′s best-known trademarks

        A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

        ?

        Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:

        ?

        ?

        Exclusive Focus on the Life Science Businesses

        The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science, which are also our reporting segments. The Enabling Functions support the operational business. In 2019, the Bayer Group comprised 392 consolidated companies in 87 countries.

        ?

        Structure of the Bayer Group

        ?

        Board of ManagementCrop Science PharmaceuticalsConsumer HealthEnabling functions

        Business Operations Are the Responsibility of the Divisions

        ?

        ph-content180x120_0The Pharmaceuticals division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.

        ?

        ch-content180x120The?Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.

        ?

        orga_crop_science_0The Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.

        ?


        Central Service Functions

        businesswoman_with_colleagues-180x120The Enabling Functions?operate as Group-wide competence centers in which business support services are bundled.

        ?

        ?


        Corporate Governance

        Dual governance system with the following governance bodies:

        ?

        Board of Management:

        five members, Chairman: Werner Baumann

        Supervisory Board:

        20 members, Chairman: Prof. Dr. Norbert Winkeljohann

        ?

        Products

        tablets-grain-seeds_300x144_1With our products, we are contributing to finding solutions to some of the?major challenges?of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving peo-ple’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.

        ?

        ?

        Bayer’s extensive?product portfolio?contains numerous globally renowned brands.

        ?

        Best-selling Bayer products are:

        • in the Pharmaceuticals field: Xarelto?, Eylea?, Adempas?, Xofigo?, Stivarga?, Mirena?-Produktfamilie, Kogenate? / Kovaltry? / Jivi?, Nexavar?, YAZ? / Yasmin? / Yasminelle?, Glucobay?, Adalat?, Aspirin? Cardio, Betaferon? / Betaseron?, Gadavist? / Gadovist? and Stellant?
        • in the Consumer Health field: Claritin?, Aspirin?, Bepanthen? / Bepanthol? Aleve?, Canesten?, Alka-Seltzer?-Produktfamilie, Elevit?, One A Day? and MiraLAX?
        • the key brands in the?agriculture field are: Confidor? / Gaucho? /Nativo?-Produktfamilie und die Prosaro?-Produktfamilie

        ?

        Locations

        The Bayer Group comprises 392 consolidated companies**?in 87 countries. Global headquarters are in Leverkusen, Germany.

        ?

        Our Employees

        On December 31, 2019, Bayer employed 103,824 (2018: 107,824)?people worldwide. In Germany we had 24,953 (2018: 25,602) employees, which was 24.0% of the total Bayer Group workforce (2018: 23.7%).

        ?

        Employees by Region and Gender in 2019

        employees_by_gender_region_2019_en
        ?
        ?

        Bayer Stock

        ?

        Bayer Group Key Data

        ?


        Bayer Group 2018 2019 Change
        ? €?million €?million %
        Sales 36,742 43,545 18.5
        EBIT1 3,454 4,189 21.3
        EBIT before special items2 6,013 7,007 16.5
        EBITDA3 9,695 9,554 -1.5
        EBITDA before special items2 8,969 11,503 28.3
        EBITDA margin before special items (in %)4 24.4 26.4 8.2
        Income before income taxes 1,886 2,880 52.7
        Net income 1,695 4,091 141.4
        Earnings per share (€)5 1.80 4.17 131.7
        Core earnings per share (€)6 5.60 6.40 14.3
        Net financial debt 35,679 34,068 -4.5
        Capital expenditures as per segment table 2,368 2,920 23.3
        Research and development expenses 5,105 5,342 4.6
        Dividend per Bayer?AG share (€) 2,80 2,80 0

        figures restated
        1-6 for definition see footnotes to alternative performance measures Bayer Group (as of Dec. 31, 2019)

        • **. fully consolidated subsidiaries (as of December. 31, 2019)
        色噜噜综合色在线视频
        <object id="6k4cv"><li id="6k4cv"></li></object>
        1. <code id="6k4cv"></code>

        2. <strike id="6k4cv"></strike>

          1. <code id="6k4cv"></code>
          2. <tr id="6k4cv"></tr>